Transplant stories

Real Treatments. Real Families. Real Hope.

Smart Cells was the first private UK stem cell bank to release samples for transplant — proving that family cord blood banking is not just about storage, but about delivering real therapies when they are needed most.

Why Stem Cell Transplants Matter

At some point in life, your child or family member may need access to stem cell therapy. Today, these treatments are being used for:

Blood cancers such as leukaemia and lymphoma
Inherited genetic disorders including thalassemia and sickle cell disease
Neurological conditions such as cerebral palsy and brain injury
Immune deficiencies and metabolic disorders
Emerging therapies for sports injuries, inflammatory conditions, and skin repair

By preserving your baby’s umbilical cord blood and tissue, you safeguard access to these life-saving and life-enhancing possibilities.

Proven Track Record

Smart Cells has released more stem cell samples for treatment than any other private UK bank, with a 100% success rate for every sample delivered to clinicians worldwide.

These samples have helped children and families across the globe face illnesses such as:

Cerebral Palsy
Thalassemia
Leukaemia
HSV Encephalitis
Immune system disorders

Each transplant is more than a statistic — it represents a child given new options, and a family given hope.

A Milestone for Families and for Science

Every successful release shows how far the field of stem cell research has advanced. What was once only a possibility is now a proven therapy.

Yet many parents are still unaware of the benefits of storing their baby’s cord blood and tissue. Smart Cells is working to change that — by raising awareness, sharing real transplant stories, and supporting research into the next generation of regenerative treatments.

Powered by FamiCord: Europe’s Stem Cell Leader in banking and use of cells

As part of the FamiCord Group, Europe’s largest family stem cell bank and one of the world’s top three:

Families gain access to 1,000,000+ stored cord blood units across the network
Therapies are supported by specialist research centres and clinical teams in 35+ countries including FamiCord Programme for brain disorders
FamiCordTx, the group’s advanced therapies division, is actively developing new cell-based treatments to extend the possibilities for families everywhere

Together, Smart Cells and FamiCord stand at the forefront of innovation, offering parents confidence today — and hope for tomorrow.

Order now Find out more

FamiCord Group releases

Patients

7800+

Expand table
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
8201	Apheresis	Autologous	Multiple Myeloma	Hematology	2015	Standard Therapy	Germany	61
8202	Apheresis	Autologous	Multiple Myeloma	Hematology	2015	Standard Therapy	Germany	64
8203	Apheresis	Autologous	Multiple Myeloma	Hematology	2015	Standard Therapy	Germany	48
8204	Apheresis	Autologous	Multiple Myeloma	Hematology	2015	Standard Therapy	Germany	49
8205	Apheresis	Allogeneic	Multiple Myeloma, Second Acute Myeloid Leukemia	Hematology	2015	Standard Therapy	Germany	64
8206	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2015	Standard Therapy	Germany	57
8207	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2015	Standard Therapy	Germany	60
8208	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2015	Standard Therapy	Germany	29
8209	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2015	Standard Therapy	Germany	73
8210	Apheresis	Allogeneic	Non-Hodgkin Lymphoma	Hematology	2015	Standard Therapy	Germany	62
8211	Apheresis	Allogeneic	Non-Hodgkin Lymphoma	Hematology	2015	Standard Therapy	Germany	22
8212	Apheresis	Autologous	Non-Hodgkin Lymphoma	Hematology	2015	Standard Therapy	Germany	61
8213	Apheresis	Allogeneic	Post–Polycythemia Vera Myelofibrosis	Hematology	2015	Standard Therapy	Germany	54
8214	Apheresis	Autologous	Primary Central Nervous System Lymphoma	Hematology	2015	Standard Therapy	Germany	61
8215	Apheresis	Autologous	Primary Central Nervous System Lymphoma	Hematology	2015	Standard Therapy	Germany	41
8216	Apheresis	Autologous	Primary Central Nervous System Lymphoma	Hematology	2015	Standard Therapy	Germany	70
8217	Apheresis	Allogeneic	Primary Myelofibrosis	Hematology	2015	Standard Therapy	Germany	70
8218	Apheresis	Allogeneic	T-Cell Non-Hodgkin Lymphoma	Hematology	2015	Standard Therapy	Germany	44
8219	Cord Tissue	Allogeneic – Unrelated	Acute Graft Versus Host Disease	Hematology	2014	Experimental Therapy	Poland	6
8220	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2014	Experimental Therapy	Poland	60,1
8221	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2014	Experimental Therapy	Poland	24,1
8222	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2014	Experimental Therapy	Poland	12,6
8223	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2014	Experimental Therapy	Poland	8,3
8224	Cord Tissue	Allogeneic – Unrelated	Birth Asphyxia; Retinopathy	Neurology	2014	Experimental Therapy	Poland	11 months
8225	Cord Tissue	Allogeneic – Unrelated	Central Motor Coordination Impairment After Hypoxic Ischemic Lesion At Birth	Neurology	2014	Experimental Therapy	Poland	2,1
8226	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2014	Experimental Therapy	Poland	4,1
8227	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2014	Experimental Therapy	Poland	15,1
8228	Cord Tissue	Allogeneic – Unrelated	Muscular Dystrophy	Neurology	2014	Experimental Therapy	Poland	6
8229	Cord Tissue	Allogeneic – Unrelated	Neuropathy	Neurology	2014	Experimental Therapy	Poland	23,6
8230	Cord Blood	Allogeneic – Unrelated	Acute Lymphoblastic Leukemia	Hematology	2014	Standard Therapy	Spain	15
8231	Cord Blood	Allogeneic – Related	Acute Lymphoblastic Leukemia	Hematology	2014	Standard Therapy	Turkey	8,8
8232	Cord Blood	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2014	Standard Therapy	Germany	45
8233	Cord Blood	Autologous	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Portugal	6
8234	Cord Blood	Allogeneic – Related	Beta Thalassemia	Hematology	2014	Standard Therapy	Germany	6
8235	Cord Blood	Autologous	Cerebral Palsy	Neurology	2014	Experimental Therapy	Portugal	4
8236	Cord Blood	Autologous	Cerebral Palsy	Neurology	2014	Experimental Therapy	UK	1
8237	Cord Blood	Autologous	Hsv Encephalitis And Nmda Receptor Antibody Encephalitis	Neurology	2014	Experimental Therapy	UK	2
8238	Cord Blood	Autologous	Hypoxia-Ischemic Encephalopathy (Hie)	Neurology	2014	Experimental Therapy	UK	3 months
8239	Cord Blood	Allogeneic – Related	Leukemia	Hematology	2014	Standard Therapy	UK	4
8240	Cord Blood	Autologous	Severe Aplastic Anemia	Hematology	2014	Standard Therapy	Germany	11
8241	Bone Marrow Family	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	35
8242	Bone Marrow Family	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	73
8243	Bone Marrow	Allogeneic	Non-Hodgkin-Lymphoma-Relapse	Hematology	2014	Standard Therapy	Germany	44
8244	Bone Marrow	Allogeneic	Severe Aplastic Anemia	Hematology	2014	Standard Therapy	Germany	60
8245	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	52
8246	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	69
8247	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	51
8248	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	69
8249	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	52
8250	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	29
8251	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	76
8252	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	48
8253	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2014	Standard Therapy	Germany	53
8254	Apheresis	Allogeneic	Acute Myeloid Leukemia – Relapse	Hematology	2014	Standard Therapy	Germany	45
8255	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2014	Standard Therapy	Germany	27
8256	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2014	Standard Therapy	Germany	44
8257	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma	Hematology	2014	Standard Therapy	Germany	46
8258	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma – Relapse	Hematology	2014	Standard Therapy	Germany	67
8259	Apheresis	Autologous	Bing–Neel Syndrome; Lymphoma	Hematology	2014	Standard Therapy	Germany	64
8260	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2014	Standard Therapy	Germany	42
8261	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2014	Standard Therapy	Germany	57
8262	Apheresis	Allogeneic	Composite Lymphoma	Hematology	2014	Standard Therapy	Germany	59
8263	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	53
8264	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	50
8265	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	63
8266	Apheresis	Autologous	Germ Cell Tumor	Hematology	2014	Standard Therapy	Germany	24
8267	Apheresis	Autologous	Lymphoma-Relapse	Hematology	2014	Standard Therapy	Germany	56
8268	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	51
8269	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	62
8270	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	58
8271	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	62
8272	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	51
8273	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	59
8274	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	68
8275	Apheresis	Allogeneic	Mantle Cell Lymphoma	Hematology	2014	Standard Therapy	Germany	60
8276	Apheresis	Autologous	Marginal Zone Lymphoma	Hematology	2014	Standard Therapy	Germany	52
8277	Apheresis	Allogeneic	Morbus Hodgkin	Hematology	2014	Standard Therapy	Germany	31
8278	Apheresis	Autologous	Morbus Hodgkin-Relapse	Hematology	2014	Standard Therapy	Germany	44
8279	Apheresis	Autologous	Morbus Hodgkin-Relapse	Hematology	2014	Standard Therapy	Germany	37
8280	Apheresis	Autologous	Morbus Hodgkin-Relapse	Hematology	2014	Standard Therapy	Germany	19
8281	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	70
8282	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	71
8283	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	60
8284	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	71
8285	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	66
8286	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	60
8287	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	53
8288	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	59
8289	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	60
8290	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	30
8291	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	64
8292	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	70
8293	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	77
8294	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	52
8295	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	60
8296	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	69
8297	Apheresis	Autologous	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	63
8298	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2014	Standard Therapy	Germany	63
8299	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2014	Standard Therapy	Germany	68
8300	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2014	Standard Therapy	Germany	49

Page 83 of 89 1 81 82 83 84 85 89

Expand table

Stem cell transplantation has become an established procedure

700,000

cord blood collections have been undertaken globally

50,000

hematopoietic stem cell transplants take place every year

400/500

of these transplants are in Europe

Our transplant stories

Smart Cells have released 24 UK
samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

100% infusion success rate

For samples released for transplant.

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

46% self | 54% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

Smart Cells releases

UK samples released

Expand table
Sample release date	Medical condition	Recipient relationship	Age of the recipient	Unit volume	Medical center	Country
2005.11	Thalassemia	Allogeneic (Sibling)	4 Years	144ml	Mount Vernon Hospital	Singapore
2005.11	Leukaemia	Allogeneic (Sibling)	Restricted	Restricted	Stem Cells and Immunology Department, Birmingham	UK
2007.02	Thalassemia	Allogeneic (Sibling)	7 Years	76ml	Kinderlink der Tu Munchen	Germany
2009.08	Cerebral Palsy	Autologous (Self)	3 Years	51ml	Duke University, North Carolina	USA
2010.01	Cerebral Palsy	Autologous (Self)	3 Years	81ml	Duke University, North Carolina	USA
2013.10	Thalassemia	Allogeneic (Sibling)	5 Years	58ml	Catherine Lewis Centre, Hammersmith	UK
2014.01	Leukaemia	Allogeneic (Sibling)	4 Years	71ml	Medizinische Hochschule, Hanover	Germany
2014.05	Cerebral Palsy	Autologous (Self)	1 year	68ml	Duke University, North Carolina	USA
2014.06	HSV Encephalitis & NMDA Receptor Antibody Virus	Autologous (Self)	2 Years	57ml	Duke University, North Carolina	USA
2014.08	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	3 Months	39ml	Duke University, North Carolina	USA
2015.02	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	6 Months	53ml	Duke University, North Carolina	USA
2015.03	Severe Combined Immune Deficiency	Autologous (Self)	3 Months	74ml	Duke University, North Carolina	USA
2015.03	Sickle Cell Disease	Allogeneic (Sibling)	2 .5 Years	57ml	BLK Hospital, New Delhi	India
2015.11	Thalassemia	Allogeneic (Sibling)	12 Years	87ml	Children’s Hospital of Pittsburgh of UPMC	USA
2016.03	Cerebral Palsy	Allogeneic (Sibling)	6 Years	101ml	Duke University, North Carolina	USA
2017.04	Lymphoblastic Leukaemia (^1)	N/A (Identical twin girls)	Restricted	125ml	Bambin Gesu Childrens’ Hospital, Rome	Italy
2017.06	Cerebral Palsy	Autologous (Self)	7 Years	82ml	Duke University, North Carolina	USA
2017.06	Cerebral Palsy	Autologous (Self)	3.4 Years	132ml	Duke University, North Carolina	USA
2018.03	Autism	Autologous (Self)	5.4 Years	73ml	Duke University, North Carolina	USA
2018.03	Cerebral Palsy	Autologous (Self)	3.4 years	132ml	Duke University, North Carolina	USA
2019.06	Cerebral Palsy	Allogeneic (Sibling)	3 Years	104ml	Duke University, North Carolina	USA
2022.02	Cerebral Palsy	Allogeneic (Sibling)	11 Years	185ml	Duke University, North Carolina	USA
2023.08	Cerebral Palsy	Allogeneic (Sibling)	3 Years	46ml	Duke University, North Carolina	USA
2024.01	Thalassaemia	Allogeneic (Sibling)	8 Years	45ml	Cincinnati Children’s Hospital Medical Center	USA